Minghui Sun

Dec 17, 2024 | mdpi.com | Minghui Sun

1. IntroductionHumanized anti-interleukin-6 receptor (IL-6R) monoclonal antibodies are used in many inflammation-related diseases, such as active rheumatoid arthritis (RA), giant cell arteritis (GCA), cytokine release syndrome (CRS), and coronavirus disease 2019 (COVID-19) [1,2,3]. Interleukin-6 (IL-6), which induces B cells to mature into immunoglobulin-secreting plasma cells, is closely associated with immune regulation and dysregulation in several diseases [4,5].

Nov 1, 2024 | jitc.bmj.com | Yi Li |Kai Zhou |Minghui Sun |Qing Huang

Regular and Young Investigator Award AbstractsBiomarkers, Immune Monitoring and Novel Technologies 8 A new syngeneic lung cancer model with KRAS and LKB double mutations for evaluating the efficacy of combined KRAS mutation targeted therapy and immunotherapy Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service.